[Federal Register Volume 64, Number 118 (Monday, June 21, 1999)]
[Notices]
[Pages 33104-33105]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-15647]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Technologies for Generation of Full-Length Mammalian cDNA.
    Date: July 26, 1999.
    Time: 8 AM to 5 PM.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 
20877.
    Contact Person: C.M. Kerwin, PHD, Scientific Review 
Administrator, Special Review, Referral and Resources Branch, 
Division of Extramural Activities, National Cancer Institute, 
National Institutes of Health, 6130 Executive Boulevard/EPN-630, 
Rockville, MD 20892-7405, 301/496-7421.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support;

[[Page 33105]]

93.398, Cancer Research Manpower; 93.399, Cancer Control, National 
Institutes of Health, HHS)

    Dated: June 14, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, National Institutes of Health.
[FR Doc. 99-15647 Filed 6-18-99; 8:45 am]
BILLING CODE 4140-01-M